Quanterix Announces Landmark Nature Study Redefining Alzheimers Disease Neuropathology Prevalence
Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced publication of a landmark study in the...